Travere Therapeutics, Inc. TVTX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Travere Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s operating margin?
- Travere Therapeutics, Inc. (TVTX) reported operating margin of -10.6% in Q1 2026.
- How has Travere Therapeutics, Inc.'s operating margin changed year-over-year?
- Travere Therapeutics, Inc.'s operating margin increased by 87.2% year-over-year, from -83.1% to -10.6%.
- What is the long-term trend for Travere Therapeutics, Inc.'s operating margin?
- Over 4 years (2020 to 2025), Travere Therapeutics, Inc.'s operating margin has grown at a -38.4% compound annual growth rate (CAGR), from -88.8% to -12.8%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.